In the E11.5 AGM region, CD41 marks type I pre-HSCs and definitive HSCs. (A) Gating strategy for fractionating the VE-cad+CD45− population into CD41high (R1, 46 ± 4/ee), CD41low (R2, 260 ± 18/ee), and CD41− (R3, 2300 ± 110/ee) subsets. R4 includes the VE-cad−CD45−CD41+ cell population. (B) Recipients were transplanted with sorted populations R1, R2, R3, and R4 after 4-d co-culture with OP9 cells (doses per recipient indicated). (C) AGM region immunostaining for type I pre-HSCs (VE-cad+CD45−CD41+). The boxed area within the top left image is shown at high magnification with individual stainings for VE-cad, CD41, or CD45 (top right). Merged images are shown for DAPI and VE-cad (bottom left) and VE-cad, CD41, and CD45 (bottom right). Arrowheads show subluminal localization of these cells. D↔V, dorsoventral orientation. Bar, 10 µm. (D) Gating strategy for subfractionating definitive HSCs on the basis of CD41 expression. (E) VE-cad+CD45+ cells sorted on the basis of CD41 expression (high, R1; low, R2; and negative, R3) from the uncultured AGM region were directly transplanted into irradiated recipients (4 ee/recipient). The CD41low fraction contained HSCs. Data are derived from three independent experiments for all experiments. VC, VE-cad.